ICCM - icecure-medical.com Debt to Book Capitalization Ratio

Corporate company logo of IceCure Medical, Ltd. (ICCM)

IceCure Medical Ltd (ICCM) minimizes surgical risks by offering painless freezing of breast and kidney neoplasms. The historical ratio of financial debt to book capitalization demonstrates the current liability structure, where the value of 0.01 shows the latest figure. Revenue growth is expected via FDA approval and sales of ProSense consumables, while stability is ensured by a loyal engineering team in Israel and the expansion of the US staff.

IceCure Medical Ltd. - ICCM Debts to Book Capitalization (period 07/04/2022 - 10/28/2026)
Flagship merchandise of IceCure Medical Ltd.

To stress-test assets, it is essential for an investor to evaluate the issuer's degree of financial autonomy. IceCure Medical Ltd (ICCM) is currently scaling its ProSense technology as it concludes critical clinical trials. The ratio of total liabilities to net assets, reflected in the shifting proportion of total debt to book capitalization, determines the bankruptcy risk. This metric compares total borrowings against equity to identify dependence on creditors. A low debt level confirms the stability of the R&D cycle.

Competitors of IceCure Medical Ltd

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|LUNG - Debts to Book Value|Debts to Book Capitalization telabio.com|CytoSorbents Corporation (CTSO) - Debt to Book Value Ratio|SRTS: Debts to Book Capitalization|Debts to Net Assets Zynex Medical|Debts to Book Capitalization ECOR (electroCore, Inc.)|Debt to Book Value vicarioussurgical.com (RBOT)|Debts to Book Capitalization IINN (Inspira Technologies)|seastarmedical.com - Debts to Book Capitalization|IRIX - Debt to Book Capitalization Ratio|Intelligent Bio Solutions (INBS) - Debt to Book Capitalization Ratio|Debt to Book Value beyondair.net XAIR|Profusa, Inc (PFSA) - Debt to Net Assets Ratio|Debts to Book Capitalization SSKN (STRATA Skin Sciences Inc.)|Debts to Book Value GCTK|NAOV: Debt to Book Capitalization Ratio|Debt to Net Assets Venus Concept Inc VERO|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio